Tissue Culture Reagents Market Highlights 2021-2029
The tissue culture reagents market is estimated to grow with a moderate CAGR during the forecast period, i.e., 2021-2029. Extensive research associated with various diseases and treatments in western countries, along with the growing investment in the development of advanced therapies are expected to fuel the progress of this market. The growth of the market can also be attributed to factors such as the increasing research in vaccine development and rising research in stem cell technology. According to the data collected from UNICEF, the global immunization coverage by selected antigens are 88% for BCG vaccine, 90% DTP1 vaccine, 85% for DTP3 vaccine, 85% MCV1 vaccine, 71% MCV2 vaccine, 48% PCV3 vaccine, 86% for POL3 vaccine and 39% ROTAC vaccine in 2019. It indicates there is a need of vaccine development. Moreover, the market for tissue culture reagents is mainly driven by biotechnology sector. Increasing awareness about stem cell culture is likely to be major factor for tissue culture reagents market. In addition, tissue culture reagents are also used in medicine, microbiology, agriculture, pharmaceuticals, food additives and cosmetics. Increasing demand for advanced technologies from biopharmaceuticals is likely to provide opportunities for tissue culture reagents market in near future. The growth of the market can be attributed to the fact that tissue culture reagents play a key role in cell-based products, manufacturing and testing of pharmaceutical drug products, and several other healthcare-related solutions. Technological advancements in pharmaceutical and biotechnology sector are expected to be major drivers for the market. However, threats from the substitutes and higher prices can be major restraint for the market.
Get more information on this report: Download Sample PDF
The market is segmented based on reagent type into media, sera, culture, and others, out of which, the culture segment is anticipated to grab the largest share by the end of 2021. The primary reason behind the major share of culture segment is the application of mammalian cell cultures in the production of mammalian pharmaceuticals and the growing demand for non-conventional drugs developed as a result of bio-production of proteomically and genetically enhanced drugs. This segment is expected to witness lucrative growth in demand over the forecast period.
On the basis of application, the biopharmaceutical manufacturing segment in the global tissue culture reagents market is projected to grow with a significant CAGR over the forecast period. This segment's high growth is attributed to the commercial expansion of major pharmaceutical companies, growing regulatory approvals for the production of cell culture-based vaccines, and an increase in the demand for monoclonal antibodies (mAbs).
Major Macro-Economic Indicators Impacting the Market Growth
According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.
Tissue Culture Reagents Market Regional Synopsis
Geographically, the market is segmented into North America, Latin America, Europe, Asia Pacific and the Middle East & Africa region. The market in the Asia Pacific is predicted to grow at the highest CAGR over the forecast period owing to the increasing demand for cell culture media and the rise in biopharmaceutical research has led to the rise of this industry. Furthermore, in 2021, the market in North America is evaluated to occupy the largest share in terms of revenue. The growing regulatory approvals for cell culture-based vaccines, growing academic and government investments in cell-based research, high life science research funding, high biopharmaceutical R&D expenditure, and the greater adoption of advanced technologies in North America are driving the cell culture market in the region. For instance, total venture capital funding for the life sciences industry for the year 2019- 2020 was more than USD 17 billion.
Get more information on this report: Download Sample PDF
The global tissue culture reagents market is further classified on the basis of region as follows:
- North America (U.S. & Canada) Market size, Y-O-Y growth & Opportunity Analysis
- Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Opportunity Analysis
- Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC, Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth & Opportunity Analysis
- Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Opportunity Analysis
- Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth & Opportunity Analysis
Market Segmentation
Our in-depth analysis of the global tissue culture reagents market includes the following segments:
By Reagent Type
- Media
- Sera
- Culture
- Others
By Applications
- Biopharmaceutical Manufacturing
- Tissue Culture and Engineering
- Gene Therapy
- Other
Growth Drivers
- Funding for cell-based research
- Rise in biopharmaceutical research
Challenges
- High cost of cell biology research
Top Featured Companies Dominating the Market
- Becton, Dickinson and Co.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Bio-Techne Corp.
- FUJIFILM Irvine Scientific, Inc.
- Cytiva Life Sciences
- Fluidigm Corp.
- GE Healthcare
- Lonza Group Ltd.
- Merck KGaA
- Sartorius AG
- Thermo Fisher Scientific Inc.
